Australian Construction Stock News

RBC Capital’s upgrade of CSL (ASX:CSL) to Outperform after the recent selloff has refocused attention on the stock. Investor interest is building around February’s half year results and the upcoming interim dividend decision. See our latest analysis for CSL. CSL’s recent selloff has left the share price at A$176.70, with a 90 day share price return of a 19.94% decline and a 1 year total shareholder return of a 34.10% decline, signalling weaker momentum despite the short term lift after the...

In January 2026, Cochlear announced that its Nucleus Nexa System, described as the world’s first smart cochlear implant system, is now available to eligible US military veterans through Department of Veterans Affairs clinics nationwide. This VA rollout meaningfully broadens access to Cochlear’s latest upgradeable, memory-enabled and ultra-light processors, underscoring the company’s role in advanced hearing technology for a large, government-backed patient base. We’ll now examine how VA-wide...

Telstra Group has become a focus for investors as they await its half-year earnings report on 19 February 2026 and the March dividend announcement, with attention sharpened by broader market uncertainty and interest rate movements. The situation highlights how Telstra’s reputation as a relatively defensive telecommunications player can attract interest when macroeconomic conditions appear unsettled. Next, we’ll examine how anticipation around Telstra’s upcoming earnings and dividend could...

In recent days, Fortescue has come under pressure as softer iron ore prices, linked to weakness in China’s property sector and rising inventories, coincided with heightened analyst scrutiny ahead of its upcoming production and half-year earnings updates. At the same time, Fortescue’s ambitious push into green hydrogen and ammonia is reshaping how investors weigh the risks of its iron ore reliance against the potential of its global clean-energy aspirations. Next, we’ll examine how...

Why APA Group Is Back on Investor Radar Trending interest in APA Group (ASX:APA) is being driven by focus on its regulated cash flows, current gas transmission spending, and involvement in hydrogen and renewable gas projects. See our latest analysis for APA Group. At a share price of A$8.84, APA’s recent 7 day share price return of 2.79% contrasts with a 30 day share price return decline of 5.05%, while the 1 year total shareholder return of 37.23% points to stronger momentum building over a...

In recent weeks, the global market landscape has been characterized by a mixed performance among equity indexes, with small-cap and value stocks leading gains over their large-cap counterparts. The Russell 2000 and S&P MidCap 400 Indexes have reached all-time highs, reflecting strong investor interest in smaller companies amid a backdrop of cooling core consumer prices and robust consumer spending. In this environment, identifying promising small-cap stocks often involves looking for those...

Westgold Resources Limited reported strong group gold production of 111,418oz for the December 2025 quarter, up from 83,937oz in the prior quarter, and maintained its fiscal 2026 production guidance of 345koz–385koz ahead of releasing full Q2 results on January 21, 2026. The decision to reaffirm guidance while lifting quarterly output signals management’s confidence in operational performance just as the company prepares to brief investors via an earnings call and webcast. Next, we’ll...

If you are wondering whether Macquarie Group at around A$206.97 is offering fair value or a potential mispricing right now, this article breaks down what the numbers are actually saying about the stock. The share price has returned 0.7% over the last 7 days, 3.2% over 30 days, 1.6% year to date, with a 9.9% decline over 1 year. The 3 year and 5 year returns stand at 24.7% and 80.3% respectively. Recent coverage has focused on how Macquarie Group is being viewed as a key player among...

Northern Star Resources (ASX:NST) recently cut its FY26 gold production forecast to a range of 1.6 to 1.7 million ounces and raised all in sustaining cost guidance, after lower sales, equipment issues, and higher royalty payments. See our latest analysis for Northern Star Resources. Despite the production downgrade and higher cost guidance, Northern Star Resources’ share price was A$27.98 as of the last close, with a 90 day share price return of 18.76% and a 1 year total shareholder return of...

ARB Corporation Limited recently reported unaudited half-year sales revenue to 31 December 2025 of A$358.0 million, representing a 1.0% decline from the prior corresponding period. The marginal revenue decrease highlights how even small shifts in demand can draw closer attention to ARB’s underlying business trends and resilience. With this slight revenue decline as a backdrop, we’ll examine what the latest update means for ARB’s broader investment narrative. Uncover the next big thing with...

PLS Group (ASX:PLS) is back in focus after AustralianSuper reduced its holding from 16.27% to 15.11%, as investors look ahead to the December quarter report and upcoming webcast. See our latest analysis for PLS Group. The A$4.74 share price comes after a 1 day share price return of 1.28%, a 30 day share price return of 20.61% and a 90 day share price return of 68.68%. The 1 year total shareholder return of 94.26% contrasts with a modest 3 year total shareholder return decline of 1.29%,...

If you are wondering whether Woodside Energy Group is priced attractively right now, the key question is whether the current share price lines up with the value of its underlying business. The stock recently closed at A$23.50, with returns of 0.8% over the last 7 days, 3.1% over 30 days, a 0.7% decline year to date, and a 2.4% decline over the past year. Over 5 years the return sits at 27.2%, and over 3 years the return is a 21.8% decline. Recent coverage of Woodside has focused on its...

In January 2026, 29Metals Limited launched a follow-on equity offering of A$149.98 million, issuing 374,955,311 ordinary shares at A$0.40 each, a A$0.14 discount per share under a Regulation S rights offering structure. This sizeable capital raise stands out for its scale relative to the existing equity base and its potential to reshape 29Metals’ capital structure through dilution and added funding flexibility. We’ll now examine how this substantial rights offering, and its implications for...

Viva Energy Group announced that long-serving Chair Robert Hill will retire on 1 March 2026, with current Director Dr Sarah Ryan named Chair elect and experienced executive Alistair Bell joining the Board as an Independent Non-Executive Director on the same date. This refresh brings energy industry depth and financial leadership to the Board, potentially influencing how Viva Energy balances operational discipline with long-term growth priorities. Against this backdrop of board renewal, we’ll...

Origin Energy has delayed the retirement of its 2,880 megawatt Eraring coal-fired power station in New South Wales from August 2027 to April 2029, after authorities identified ongoing system security and reliability risks during Australia’s energy transition. This extension highlights how aging coal capacity remains critical to grid stability while renewable generation, storage projects, and major transmission upgrades are still being developed. We’ll now examine how extending Eraring’s...

The Australian market is experiencing a turbulent period, with losses gathering steam amid global economic uncertainties and delayed U.S. trading activity. Despite these challenges, investors continue to seek opportunities in various corners of the market, including penny stocks. While the term 'penny stock' might seem outdated, it still signifies potential growth opportunities in smaller or newer companies that can offer value when backed by strong financials.

Mesoblast (ASX:MSB) is back in focus after feedback from the U.S. FDA on its rexlemestrocel L cell therapy, which targets chronic discogenic low back pain and is directly linked to opioid use reduction. See our latest analysis for Mesoblast. Despite the positive FDA feedback, Mesoblast’s recent share price momentum has been soft, with a 7 day share price return of a 7.0% decline and a 30 day share price return of a 12.7% decline, while the 3 year total shareholder return of 177.6% points to a...

James Hardie Industries (ASX:JHX) is back in focus after announcing plans to close its Fontana, California, and Summerville, South Carolina manufacturing plants within 60 days and to consolidate capacity under a broader optimization program. See our latest analysis for James Hardie Industries. The plant closures come after a sharp share price rally, with a 15.54% 30 day share price return and a 13.02% year to date share price return, even as the 1 year total shareholder return shows a 36.53%...

We feel now is a pretty good time to analyse Minerals 260 Limited's ( ASX:MI6 ) business as it appears the company may...

Djerriwarrh Investments (ASX:DJW) has put out its H1 2026 numbers, reporting total revenue of A$24.8 million and basic EPS of A$0.079, with trailing twelve month EPS of A$0.146 on revenue of A$51.6 million. Over the last three reported halves, revenue has moved between A$24.8 million and A$26.7 million while basic EPS has ranged from A$0.067 to A$0.081. This gives investors a clear view of how earnings per share have tracked relative to a fairly steady top line. With trailing net profit...

Key Insights The considerable ownership by retail investors in Saturn Metals indicates that they collectively have a...

Even though MetalsTech Limited ( ASX:MTC ) has fallen by 14% over the past week , insiders who sold AU$2.0m worth of...

Unfortunately for some shareholders, the Qoria Limited ( ASX:QOR ) share price has dived 29% in the last thirty days...

Adheris Health Limited ( ASX:AHE ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...